Literature DB >> 12352676

Vestibular evoked myogenic potentials in delayed endolymphatic hydrops.

Yi-Ho Young1, Tsung-Wei Huang, Po-Wen Cheng.   

Abstract

OBJECTIVE/HYPOTHESIS: Vestibular evoked myogenic potential (VEMP) has become an established test to explore the sacculo-collic reflex. The study aims to investigate the VEMPs in cases of delayed endolymphatic hydrops because greatly dilated saccule was observed in histopathological specimens of delayed endolymphatic hydrops. STUDY
DESIGN: Prospective study.
METHODS: Twenty patients with delayed endolymphatic hydrops were subjected to pure-tone audiometry, caloric testing, and VEMP test. Delayed VEMP was defined as the latency of peak I exceeding 22.6 milliseconds or of peak II exceeding 33.1 milliseconds. Interaural amplitude difference over the sum of amplitudes of both ears was measured, and when the ratio exceeded 0.36, it was identified as augmented VEMP or depressed VEMP depending on whether the amplitude of the lesioned side was greater or less than the opposite side.
RESULTS: The VEMP test revealed that 9 patients (45%) were normal, 6 (30%) exhibited absent VEMPs, and 5 (25%) displayed abnormal VEMPs, including delayed VEMPs in 2, depressed VEMPs in 2, and augmented VEMPs in 1. The caloric test indicated that 9 (47%) of the 19 ears exhibited normal caloric response, whereas 10 ears displayed abnormal caloric responses including canal paresis in 8 and absent caloric response in 2. Six ears had preserved both the caloric response and the VEMPs, whereas no ear demonstrated both absent caloric response and absent VEMPs.
CONCLUSIONS: The residual caloric as well as saccular functions after ear insult may determine whether delayed endolymphatic hydrops will occur. These findings suggest that patients with sudden deafness or juvenile unilateral total deafness should undergo caloric testing and VEMP test to predict the occurrence of delayed endolymphatic hydrops in the future.

Entities:  

Mesh:

Year:  2002        PMID: 12352676     DOI: 10.1097/00005537-200209000-00018

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  8 in total

Review 1.  Vestibular-evoked myogenic potentials eliciting: an overview.

Authors:  Anna Eleftheriadou; Eleftherios Koudounarakis
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-10-21       Impact factor: 2.503

2.  [Preoperative determination of nerve of origin in patients with vestibular schwannoma. German version].

Authors:  T Rahne; S Plößl; S K Plontke; C Strauss
Journal:  HNO       Date:  2017-12       Impact factor: 1.284

3.  Preoperative determination of nerve of origin in patients with vestibular schwannoma.

Authors:  T Rahne; S Plößl; S K Plontke; C Strauss
Journal:  HNO       Date:  2018-01       Impact factor: 1.284

4.  Abnormal Cervical Vestibular-Evoked Myogenic Potentials Predict Evolution of Isolated Recurrent Vertigo into Meniere's Disease.

Authors:  Sun-Uk Lee; Hyo-Jung Kim; Jeong-Yoon Choi; Ja-Won Koo; Ji-Soo Kim
Journal:  Front Neurol       Date:  2017-09-04       Impact factor: 4.003

5.  Optimized preoperative determination of nerve of origin in patients with vestibular schwannoma.

Authors:  Torsten Rahne; Stefan K Plontke; Laura Fröhlich; Christian Strauss
Journal:  Sci Rep       Date:  2021-04-21       Impact factor: 4.379

6.  Ipsilateral and contralateral vestibular schwannomas in unilateral long-term deaf ears.

Authors:  Shih-Ming Chu; Yi-Ho Young
Journal:  Eur Arch Otorhinolaryngol       Date:  2007-02-16       Impact factor: 3.236

Review 7.  Diagnostic Value of Vestibular Evoked Myogenic Potentials in Endolymphatic Hydrops: A Meta-Analysis.

Authors:  Sulin Zhang; Yangming Leng; Bo Liu; Hao Shi; Meixia Lu; Weijia Kong
Journal:  Sci Rep       Date:  2015-10-12       Impact factor: 4.379

8.  Vestibular evoked myogenic potentials in affected and asymptomatic ears in unilateral Ménière's disease.

Authors:  Súnia Ribeiro; Roberta R de Almeida; Heloisa H Caovilla; Maurício M Ganança
Journal:  Braz J Otorhinolaryngol       Date:  2006-01-02
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.